MTX Tapering After Biologic — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — After sustained remission following biologic withdrawal cautious Methotrexate tapering may be considered but carries a higher relapse risk than biologic tapering; slow reduction with close monitoring is essential
EULAR 2022 recommends a sequential tapering approach: biologic first then csDMARD. After sustained remission for at least 6-12 months following successful biologic withdrawal Methotrexate dose reduction can be cautiously attempted. However csDMARD tapering carries a higher relapse risk than biologic tapering (approximately 50-70% relapse rate with complete csDMARD withdrawal vs 30-50% with biologic withdrawal). Reduction should be gradual (e.g. 2.5 mg reduction every 3-6 months) with regular disease activity monitoring. Complete drug-free remission is achievable in only a minority (approximately 10-20%) of RA patients.
Reference: EULAR 2022 RA recommendations; van den Broek M et al 2014 tapering strategies